CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well CCI-779 works in treating patients with soft tissue
sarcoma or gastrointestinal stromal tumor. Drugs used in chemotherapy, such as CCI-779, work
in different ways to stop tumor cells from dividing so they stop growing or die.